RESEARCH CONFERENCES ESF-EMBO Symposium Synthetic Biology of Antibiotic Production Hotel Eden Roc, Sant Feliu de Guixols (Costa Brava) Spain 2-7 October 2011 Chair: Eriko Takano, Microbial Physiology, University of Groningen, NL Co-Chairs: Roel Bovenberg, DSM Biotechnology Center, Delft, NL and Centre for Synthetic Biology, University of Groningen, NL; Rainer Breitling, Groningen Bioinformatics Centre, University of Groningen,
NL and Institute of Molecular, Cell & Systems Biology, University of Glasgow, UK With support from:
DSM – the Life Sciences and Materials Sciences Company www.esf.org Sunday 2 October Monday 3 October
Session 1: General Synthetic Biology 1 Chair:Name, Affiliation – to be confirmed 09.00-09.30 Roy Kishony Harvard University, US The ecology of antibiotics Christina Smolke Stanford, US Molecular controllers and their application in advancing metabolic pathway design in yeast
Tobias Bollenbach IST, Austria Resolution of gene regulatory conflicts caused by combinations of antibioticsMarkus Schmidt IDC, AT Biosafety and Public Dialogue in Synthetic Biology
Barry Canton Ginkgo BioWorks, US A pipeline for organism engineering at Ginkgo BioWorks
Rebecca Jane Miriam Goss University of East Anglia, UK Elucidating and Exploiting Biosynthesis: Synthetic Biology Approaches to Access Novel Uridyl Peptide Antibiotics
Alfonso Jaramillo Institute of Systems and Synthetic Biology, FR Engineering and characterization of novel regulatory elements to control gene expression in E. coli
Session 2: General Synthetic Biology 2 Chair:Name, Affiliation – to be confirmed Luis Serrano CRG, ES A quantitative systems biology study on a model bacterium
Nili Ostrov Columbia University, US Cell Engineering via Reiterative Recombination in Yeast
Todd Peterson Life Technologies Corp, US Design, synthesis, assembly technologies for synthetic biology engineeringJörg Stelling ETH, CH Computational design of synthetic gene circuits
Eric Tippmann Cardiff University, UK New approaches for the optimization of translational and post-translational modification of proteins
1 min. Poster presentations (Poster 1-16)
Tuesday 4 October
Session 3: Filamentous Fungal Systems 1 Chair:Name, Affiliation – to be confirmed 09.00-09.30 Nancy Keller University of Wisconsin-Madison, US Unlocking the fungal treasure chest
Sabine Albermann Westfaelische Wilhelms-Universitaet, DE Approaches for directed strain improvement targeting enhanced biosynthesis of gibberellic acid in Fusarium fujikuroi
Russell Cox University of Bristol, UK Reprogramming Fungal Polyketide SynthasesAxel Brakhage HKI, DE Activation of fungal silent gene clusters
Jan A.K.W. Kiel University of Groningen, NL Secondary metabolism in filamentous fungi: there is more to it than just the cytosolFungal survival strategies against antibiotics
Stefan Olsson University of Copenhagen, DK Exploring fungal-bacterial interactions for discovering new bioactive substances and their mechanisms of action
Session 4: Filamentous Fungal Systems 2 Chair:Name, Affiliation – to be confirmed 15.00-15.30 Jens Nielsen Chalmers University of Technology, SE Synthetic Biology Tools for Improving Fungal Production of Antibiotics
Arthur Ram Leiden University, NL Secondary metabolite production in Aspergillus niger at near zero specific growth rates
Daniel Scharf Leibniz Institute for Natural Product Research and Infection Biology e.V., DE Gliotoxin pathway reconstruction as a prerequisite for pathway engineering
Tom Simpson University of Bristol, UK Biosynthesis and Mutasynthesis of Trans-AT Polyketides: Mupirocin and Thiomarinol
Joseph Strauss BOKU University and Austrian Institute of Technology, AT Histone H3 de-methylases are involved in regulating primary and secondary metabolism
1 min. poster presentation (Posters 17-32)
Wednesday 5 October Chair:Name, Affiliation – to be confirmed 09.00-09.30 Mohamed Marahiel University of Marburg, DE Structural insights into the NRPS assembly machinery
Christopher Corre University of Warwick, UK New chemical keys to unlock the production of novel microbial antibiotics
Anna Eliasson Lantz Technical University of Denmark, DK Application of Synthetic Promoter Library for modulation of actinorhodin production in Streptomyces coelicolorRolf Mueller Saarland University, DE Title to be confirmed
Juan Pablo Gomez-Escribano John Innes Centre, UK Engineering Streptomyces coelicolor for the expression of heterologous gene clusters
Luciana Gonzaga De Oliveira University of Campinas, BR Molecular fingerprint in actinomycetesMycelium differentiation and antibiotic production in liquid cultures of Streptomyces: Biotechnological applications
Justin Nodwell McMaster University, CA Remodeling secondary metabolism with synthetic chemical signals
Session 6: Actinomyces Systems 2 Chair:Name, Affiliation – to be confirmed 15.00-15.30 Peter Leadlay Cambridge University, UK Defining modularity in polyketide synthase-containing pathways
Hiroyasu Onaka Toyama Prefectural University, JP Biosynthesis and genetic engineering of goadsporin, one of thiazole and oxazole containing peptides (TOPs) produced by Streptomyces sp. TP-A0584Wolfgang Wohlleben Tübingen University, DE Supply of building blocks for antibiotic biosynthesis
Bohdan Ostash Ivan Franko National Univerisyt of Lviv, UA Exploring and exploiting moenomycin biosynthesis to develop new class of antibiotics: contributions of genomics
Hrvoje Petkovic Acies Bio, Ltd., SI New insights into substrate supply and regulation of FK506 biosynthesis and their implications for bioprocess development and drug discovery
Sergey Zotchev Norwegian University of Science and Technology, NO Genome mining of marine actinobacteria for secondary metabolite biosynthesis gene clusters: tools and applications
1 min. poster presentations (Posters 33-48)
Thursday 6 October
Session 7: Tools and Host Structures 1 Chair:Name, Affiliation – to be confirmed 09.00-09.30 Arnold Driessen University of Groningen, NL Secondary metabolite formation by Penicillium chrysogenum Haruo Ikeda Engineered streptomyces host for heterologous expression of secondary metabolism
Julia Bandow Ruhr-Universität Bochum, DE Beyond Identification of Antimicrobial Compounds: Elucidating Antibiotic Mechanisms of ActionBeatrix Suess Frankfurt University, DE Engineered riboswitches - an alternative means to control gene expression Michael Fischbach UCSF, US A gene-to-molecule approach to the discovery and characterization of natural products Chemically coded two-step synthesis of lactones
Ana Lorena Arabolaza Instituto de Biología Molecular y Celular de Rosario-CONICET, AR Cell host design for the production of malonyl-CoA based compounds
Marnix H Medema University of Groningen, NL Automated Mining and Synthetic Biology Implementation of Secondary Metabolite Biosynthesis Gene ClustersEngineering a Natural Product Chemicopia
Session 8: Tools and Host Structures 2 Chair:Name, Affiliation – to be confirmed 15.00-15.30 Kristala Jones Prather MIT, US Parts, devices, and chassis in support ofmetabolic engineering
Anne-Gaëlle Planson University of Evry, FR Therapeutic production in Escherichia coli using retrosynthetic design of metabolic pathways
Christian Rausch Royal DSM N.V., NL NRPSpredictor2: an established method for the prediction of NRPS adenylation domain specificity – update and examples of applications
Adam Spargo University of Exeter, UK Rule-based simulation of synthetic integron construction
Colin Lazarus University of Bristol, UK Molecular systems development for studying and manipulating natural product biosynthesis
Antonio Starcevic University of Zagreb, Zagreb, Croatia
Modelling of homologous recombination in modular polyketide synthases combined with synthetic biology as a strategy for producing biologically active lead compoundsChris Voigt Refactoring Prokaryotic Gene ClustersForward Look Plenary Discussion Friday 7 October
Background Lysosomes are single membrane-bound acidic intracellular compartments that break down cellular waste products, fats, carbohydrates, proteins, and other macromolecules into simple compounds. Normal lysosome function enables cells to efficiently mobilize and recycle cellular constituents, but also prevents the accumulation of damaged organelles, misfolded proteins, and invading mic
A pragmatic and cost-effective strategy of a combinationtherapy of interferon alpha-2b and ribavirin for the treatmentMarkus Sagmeistera,b, John B. Wongb, Beat Mullhauptc andBackground Combination of interferon (IFN) alpha andcombination therapy dominates all other strategies. Inribavirin is considered the standard treatment for patientsgenotype 1 infection, 48 weeks of combination therapy f